Literature DB >> 31739942

Malignant Soft-Tissue Sarcomas.

Jeremy M Brownstein1, Thomas F DeLaney2.   

Abstract

Soft-tissue sarcomas are cancerous growths of mesenchymal tissues, most commonly arising from fat, muscles, and other connective tissues. Sarcomas are rare, representing only a small fraction of solid malignant tumors. Because of their scarcity and a relative paucity of data, the management of sarcomas can be challenging, especially for those who infrequently encounter these tumors. Herein, the authors review the current literature regarding the diagnosis, workup, and treatment of adult soft-tissue sarcomas.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extremity sarcoma; Radiation therapy; Retroperitoneal sarcoma; Soft-tissue sarcoma

Mesh:

Year:  2019        PMID: 31739942     DOI: 10.1016/j.hoc.2019.08.022

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

Review 1.  Immune checkpoint inhibitor resistance in soft tissue sarcoma.

Authors:  Vanessa Eulo; Brian A Van Tine
Journal:  Cancer Drug Resist       Date:  2022-04-06

2.  Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and Combined Therapy for Advanced Sarcoma.

Authors:  Weitao Yao; Xinhui Du; Jiaqiang Wang; Xin Wang; Peng Zhang; Xiaohui Niu
Journal:  Onco Targets Ther       Date:  2022-06-14       Impact factor: 4.345

3.  Association between microRNA 671 polymorphisms and the susceptibility to soft tissue sarcomas in a Chinese population.

Authors:  Peng Zhang; Xinling Li; Lingling Huang; Fulan Hu; Xiaoying Niu; Yang Sun; Weitao Yao
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

4.  Lymphatic Complications Prevention and Soft Tissue Reconstruction after Soft Tissue Sarcoma Resection in the Limbs.

Authors:  Mario F Scaglioni; Matteo Meroni; Elmar Fritsche; Bruno Fuchs
Journal:  Medicina (Kaunas)       Date:  2022-01-02       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.